In 2016, the World Health Organization (WHO) called for the elimination of viral hepatitis as a major public health threat by 2030, setting out a set of targets in order to achieve this.
Our programme focuses on health systems, policy, and screening aspects of viral hepatitis, including hepatitis C virus (HCV) micro-elimination, hepatitis B virus (HBV) testing and linkage to care, and simplified and novel diagnostic tools for viral hepatitis.
Some of our current research includes:
- HBV-COMSAVA (Hepatitis B virus COMmunity Screening and Vaccination in Africans) research project in the greater Barcelona area to test and link patients to care.
- Hep C Free Baleares. HCV micro-elimination programme in the Balearic Islands (Mallorca, Menorca, and Ibiza).
- The Lancet-EASL Commission on Liver Health in Europe, leading the working group on stigma.
- Late presentation to viral hepatitis care in Spain and in Europe.
- A global review of hepatitis C micro-elimination programmes.
- Implementation of simplified diagnostic tools for the detection of viral hepatitis in LMICs.
- A review of viral hepatitis testing policies.
- Viral hepatitis policy indices (Lancet GastroHep Viral Hepaitis Commission index and Hep-CORE).
Hepatitis B Virus COMmunity Screening and Vaccination in Africans
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.